Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CDH4 antisense RNA 2 (CDH4-AS2) is presumed to be a long non-coding RNA located at or near the CDH4 (Cadherin-4) gene locus. While lncRNAs in this region, such as linc-cdh4-2, have been implicated in suppression of migration and invasion in cancer cell models (notably HCC), the specific functional identity and role of CDH4-AS2 remain poorly characterized in the literature and biological databases. There is some evidence that overexpression of antisense lncRNAs at CDH4 may upregulate R-cadherin (CDH4), decrease RAC1 expression, and inhibit cell migration—suggesting a tumor suppressor function[4]. However, direct therapeutic targeting of CDH4-AS2 has not been established. Limitations: - There is no confirmatory evidence that "CDH4-AS2" is a formally recognized molecule in major databases; it may be mis-labeled, predicted, or not yet widely annotated in canonical resources. - Most functional understanding in the literature comes from related or overlapping entities (e.g., linc-cdh4-2), not the exact term CDH4-AS2[4]. Summary: CDH4-AS2 is a likely long non-coding antisense RNA associated with the CDH4 gene, potentially with tumor suppressor function in some cancers via modulation of cell migration and invasion, but it is neither a conventional drug target nor well-defined in current canonical resources[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CDH4 antisense RNA 2 (CDH4-AS2).